N-acetyl cysteine in the treatment of obsessive compulsive and related disorders: a systematic review
Data(s) |
01/01/2015
|
---|---|
Resumo |
Obsessive compulsive and related disorders are a collection of debilitating psychiatric disorders in which the role of glutamate dysfunction in the underpinning neurobiology is becoming well established. N-acetyl cysteine (NAC) is a glutamate modulator with promising therapeutic effect. This paper presents a systematic review of clinical trials and case reports exploring the use of NAC for these disorders. A further objective was to detail the methodology of current clinical trials being conducted in the area. |
Identificador | |
Idioma(s) |
eng |
Publicador |
Korean College of Neuropsychopharmacology |
Relação |
http://dro.deakin.edu.au/eserv/DU:30072821/dean-nacetylcysteine-2015.pdf http://www.dx.doi.org/10.9758/cpn.2015.13.1.12 http://www.ncbi.nlm.nih.gov/pubmed/25912534 |
Direitos |
2015, Korean College of Neuropsychopharmacology |
Palavras-Chave | #Glutamate #Obsessive-compulsive disorder #Review #Trichotillomania #acetylcysteine #systematic |
Tipo |
Journal Article |